Silva Holtfreter (Greifswald / DE), Stefan Weiss (Greifswald / DE), Tanja C. Meyer (Greifswald / DE), Frieder Schmiedeke (Greifswald / DE), Clemens Cammann (Greifswald / DE), Marcus Dörr (Greifswald / DE), Stephan B. Felix (Greifswald / DE), Hans J. Grabe (Greifswald / DE), Georg Homuth (Greifswald / DE), Christian Kohler (Greifswald / DE), Cedric Mahncke (Greifswald / DE), Stephan Michalik (Greifswald / DE), Matthias Nauck (Greifswald / DE), Nele Friedrich (Greifswald / DE), Stefanie Samietz (Greifswald / DE), Henry Völzke (Greifswald / DE), Uwe Völker (Greifswald / DE), Barbara Bröker (Greifswald / DE)
Toxic shock syndrome (TSS) is an acute life-threatening disease caused by superantigens (SAg) of the pathobiont Staphylococcus aureus, foremost by toxic shock syndrome toxin-1 (TSST-1). While most adults are protected by TSST-1-neutralizing antibodies, up to 15% of the population remains at risk. Are they unable to mount an effective antibody response to TSST-1? To identify determinants of the anti-TSST-1 antibody response, we examined 976 participants of the German population-based epidemiological Study of Health in Pomerania (SHIP-TREND-0). We profiled the anti-S. aureus antibody response, including anti-TSST-1 antibody levels, using immuno-proteomics, analyzed the nasal colonization with TSST-1-encoding S. aureus strains, and performed a genome-wide association analysis of genetic risk factors. TSST-1-specific serum IgG levels varied over a range of 4.2 logs and were elevated by a factor of 12.3 upon nasal colonization with TSST-1-encoding S. aureus. Moreover, the anti-TSST-1 antibody levels were strongly associated with single nucleotide variants in the HLA class II gene loci. HLA typing revealed that HLA-DRB1*03:01 and HLA-DQB1*02:01 were positively, and HLA-DRB1*01:01 as well as HLA-DQB1*05:01 negatively associated with the anti-TSST-1 antibody levels. We also demonstrate that the HLA haplotype can be accurately determined from array-based genotyping data using the newly published Four-digit Multi-ethnic HLA v2 (2022) algorithm. To conclude, both toxin exposure and HLA alleles affect the human antibody response to TSST-1. These findings suggest that immunizing susceptible individuals with a detoxified TSST‑1 vaccine could provide protection against TSS in the future, encouraging efforts to develop such a vaccine. Moreover, the array-based HLA prediction promises new insights into the genetics of infectious diseases, autoimmune disorders, immune deficiencies, and inflammatory disorders.
We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.